Lessons Learned in Neuroscience Drug Development: How Biomarker-based, Evidence-driven Decisions Enable Successful Outcomes, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how biomarker-supported endpoints and early evidence strategies can strengthen neuroscience drug development. The featured speakers will discuss target engagement, patient selection and outcome measures across Alzheimer's disease and psychiatric trials. Attendees will also explore how these approaches can help detect treatment effects earlier, inform go/no-go decisions and reduce uncertainty before larger late-phase studies.

TORONTO, Oct. 27, 2026 /PRNewswire/ -- Early-phase neuroscience trials have traditionally focused primarily on establishing safety and tolerability. From Alzheimer's disease to psychiatry, early development strategies can also generate meaningful evidence of target engagement and potential drug efficacy to inform future investment decisions. While trials in these indications enroll distinct populations with distinct challenges, both require the same fundamentals: understanding and demonstrating meaningful target engagement to build confidence in future development decisions. This webinar explores how evidence-driven biomarker and endpoint strategies can strengthen early neuroscience clinical trials and inform development decisions.

The featured panelists will explore how lessons learned in recent drug approvals for Alzheimer's disease can be applied across other areas of neuroscience, including psychiatric development. Incorporating the right clinical assessments, along with sensitive biomarkers, as part of a comprehensive endpoint strategy enables insight into treatment effects, even in an early-phase study with limited participants.

Novel biomarkers can also play a critical role in identifying sub-populations most likely to respond to a particular drug mechanism, further enabling proof of target engagement in small, early development studies. The featured panelists will discuss how innovative early evidence strategies can help sponsors evaluate whether a therapeutic approach is having the intended effect, refine endpoint and patient-selection strategies and make more informed decisions before advancing into larger, more costly studies.

Through perspectives spanning clinical trial endpoints in Alzheimer's disease and psychiatry, attendees will gain practical insights into how thoughtful early development strategies can holistically provide safety and tolerability data, reduce uncertainty in drug efficacy and build a stronger foundation for later-phase neuroscience development.

Register for this webinar to learn how biomarker-supported endpoints and evidence-driven strategies can strengthen neuroscience clinical trials and support earlier development decisions.

Join experts from the Thermo Fisher Scientific team that supports Clario Endpoint Data Solutions, Todd Rudo, MD, EVP, Chief Medical Officer; David Scott, PhD VP, Medical and Scientific Affairs; Mark Opler, PhD, MPH, Chief Research Officer, eCOA Neuroscience; and Vrutangkumar V. Shah, PhD, Director, Scientific Affairs, for the live webinar on Tuesday, November 10, 2026, at 11am EST (5pm CET / EU-Central).

For more information, or to register for this event, visit Lessons Learned in Neuroscience Drug Development: How Biomarker-based, Evidence-driven Decisions Enable Successful Outcomes.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks